Education
About Us
Working with TipRanks
Follow Us
Celularity (CELU)
NASDAQ:CELU
CELU Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.00 - $5.22
Previous Close$2.13
Volume115.00K
Average Volume (3M)418.52K
Market Cap
$78.55M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.67
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding23,949,228
10 Day Avg. Volume310,128
30 Day Avg. Volume418,525
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1.50Price Target Upside-54.27% Downside
Rating ConsensusHold
Number of Analyst Covering0
Celularity News
CELU FAQ
What was Celularity’s price range in the past 12 months?
Celularity lowest stock price was $1.00 and its highest was $5.22 in the past 12 months.
What is Celularity’s market cap?
Celularity’s market cap is $78.55M.
When is Celularity’s upcoming earnings report date?
Celularity’s upcoming earnings report date is Aug 18, 2025 which is in 16 days.
How were Celularity’s earnings last quarter?
Currently, no data Available
Is Celularity overvalued?
According to Wall Street analysts Celularity’s price is currently Overvalued.
Does Celularity pay dividends?
Celularity does not currently pay dividends.
What is Celularity’s EPS estimate?
Celularity’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celularity have?
Celularity has 23,949,228 shares outstanding.
What happened to Celularity’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Celularity?
Currently, no hedge funds are holding shares in CELU
Celularity Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$1.50 (-54.27% Downside)
$1.50 (-54.27% Downside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 3.9%
Last 30 Days ▼ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.12%
12-Months-Change
Fundamentals
Return on Equity
-232.51%
Trailing 12-Months
Asset Growth
118.29%
Trailing 12-Months
Company Description
Celularity
Celularity Inc. (NASDAQ: CELU) is a biopharmaceutical company focused on developing innovative, off-the-shelf allogeneic cellular therapies derived from the postpartum placenta. The company operates primarily in the biotechnology and life sciences sectors, with core products and services centered around cellular therapies for cancer, infectious diseases, and degenerative diseases. Celularity leverages its proprietary technology platform to create advanced therapeutics designed to enhance the body's ability to fight disease, with a commitment to improving patient outcomes.
Technical Analysis
Generation Bio
―
Lantern Pharma
―
Repare Therapeutics
―
Shattuck Labs
―
FibroBiologics, Inc.
―
Ownership Overview
35.62% Insiders
2.57% Mutual Funds
3.62% Other Institutional Investors
56.04% Public Companies and
Individual Investors